The contribution of South Africans to the subject of Dilated Cardiomyopathy

Cardiovascular Journal of Africa

Volumn 20, Issue 1, 2009, Pages 11-16

  Watkins, David A ^a,b   Mayosi, Bongani M ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FAS ANTIGEN; IMMUNOGLOBULIN G3; NICOTINAMIDE; PENTOXIFYLLINE; THIAMINE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; BERIBERI; CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTINUOUS HEMOFILTRATION; DISEASE COURSE; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; MALNUTRITION; MEDLINE; MORBIDITY; MORTALITY; MYOCARDITIS; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PERICARDIOTOMY; PERIPARTUM CARDIOMYOPATHY; REVIEW; RHEUMATIC HEART DISEASE; SOUTH AFRICA;

CARDIOLOGY; CARDIOMYOPATHY, DILATED; ENDOCARDIUM; HISTORY, 20TH CENTURY; HUMANS; SOUTH AFRICA;

EID: 64649105256     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Akinkugbe OO, Nicholson GD, Cruickshank JK. Heart disease in blacks of Africa and the Caribbean. Cardiovasc Clin 1991; 2 1: 377-391.
2. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005; 112: 3577-3583.
3. Gillanders AD. Nutritional heart disease. Br Heart J 1951; 13: 177- 196.
4. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: A systematic review. Int J Cardiol 2008; 131(2): 168-179
5. Rose AG, Beck W. Dilated (congestive) cardiomyopathy: a syndrome of severe cardiac dysfunction with remarkably few morphological features of myocardial damage. Histopathology 1985; 9: 367-379.
6. Bohm GM. South African endomyocardiopathy and endomyocardial fibrosis: a critical review. Rev Inst Med Trop Sao Paulo 1968; 10: 88-108.
7. Higginson J, Gillanders AD, Murray J F. The heart in chronic malnutrition. Br Heart J 1952; 14: 213-224.
8. Becker BJ, Chatgidakis CB, Van Lingen B. Cardiovascular collagenosis with parietal endocardial thrombosis; a clinicopathologic study of forty cases. Circulation 1953; 7: 345-356.
9. Grusin H. Acute reversible heart failure in Africans. Circulation 1957; 16: 27-35.
10. Schwartz MB, Schamroth L, Seftel HC. The pattern of heart disease in the urbanized (Johannesburg) African. Med Proc 1958; 4: 275-278.
11. Cosnett JE. Heart disease in the Zulu: especially cardiomyopathy and cardiac infarction. Br Heart J 1962; 24: 76-82.
12. Stein H, Shnier MH, Wayburne S, Isaacson C. Cardiomyopathy in African children. Arch Dis Child 1964; 39: 610-617.
13. Shaper AG. Review: cardiomegaly of unknown origin in South Africa. Trop Geogr Med 1968; 20: 291-297.
14. Seftel H, Susser M. Maternity and myocardial failure in African women. Br Heart J 1961; 23: 43-52.
15. Reid J V. Postpartal cardiomyopathy. S Afr Med J 1961; 35: 165-168.
16. Korb G. Heart diseases of unknown etiology: problems of terminology and classification. Recent Adv Stud Cardiac Struct Metab 1973; 2: 9-16.
17. Frontmatter. Cardiomyopathies. In: Bajusz E, Rona G, eds. Recent Advances in Studies on Cardiac Structure and Metabolism. Baltimore, Maryland: University Park Press, 1973.
18. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-673.
19. Bradlow BA, Zion MM, Fleishman SJ. Heart disease in Africa, with particular reference to southern Africa. Am J Cardiol 1964; 13: 650- 669.
20. Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995; 25: 118-123.
21. McGlashan ND. Southern African cardiomyopathy in the Republic of South Africa, 1978-1980. Afr J Med Med Sci 1988; 17: 33-46.
22. Powell SJ, Wright R. Cardiomyopathy in Durban. S Afr Med J 1965; 39: 1062-1066.
23. Maharaj B. Causes of congestive heart failure in black patients at King Edward VIII Hospital, Durban. Cardiovasc J S Afr 1991; 2: 31-32.
24. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371: 915-922.
25. Isaacson C. The changing pattern of heart disease in South African Blacks. S Afr Med J 1977; 52: 793-798.
26. Steenekamp JH, Simson I W, Theron W. Cardiovascular causes of death at Tshepong Hospital in 1 year, 1989-1990. A necropsy study. S Afr Med J 1992; 81: 142-146.
27. Kallichurum S. Major aetiological types of heart failure in the Bantu in Durban. S Afr Med J 1969; 43: 250-252.
28. Schrire V. The racial incidence of the less common forms of heart disease at Groote Schuur Hospital, Cape Town, 1952-61. S Afr Med J 1964; 38: 598-601.
29. Seftel HC. Cardiomyopathies in Johannesburg Bantu. S Afr Med J 1973; 47: 321-324.
30. Swift PJ. Dietary iron overload as a cause of idiopathic cardiomyopathy in South African blacks: the role of free iron/radicals. S Afr Med J 1996; 86: C17-C21.
31. Brandt V, Keeley KJ, Metz J, Seftel H, Soldin P. Red cell thiamine concentration in idiopathic cardiomyopathy. S Afr J Med Sci 1965; 30: 64-66.
32. Seftel HC, Metz J, Lakier JB. Cardiomyopathies in Johannesburg Bantu. I. Aetiology and characteristics of beriberi heart disease. S Afr Med J 1972; 46: 1707-1713.
33. Seftel HC. Treatment of cardiomypathies in Johannesburg Africans. Recent Adv Stud Cardiac Struct Metab 1973; 2: 771-776.
34. Naidoo D P, Rawat R, Dyer RB, Sadhabiriss A, Makgoba M W. Cardiac beriberi. A report of 4 cases. S Afr Med J 1987; 72: 283-285.
35. Seftel HC, Metz J, Lakier JB. Aetiology of cardiomyopathy in Johannesburg Africans. Recent Adv Stud Cardiac Struct Metab 1973; 2: 165-180.
36. Seftel HC. Cardiomyopathies in Johannesburg Bantu. II. Aetiology of idiopathic cardiomyopathy. S Afr Med J 1972; 46: 1823-1828.
37. Seftel HC. Diseases in urban and rural Black populations. S Afr Med J 1977; 51: 121-123.
38. Tobias SL, van der Westhuyzen J, Davis RE, Icke GC, Atkinson PM. Alcohol intakes and deficiencies in thiamine and vitamin B6 in black patients with cardiac failure. S Afr Med J 1989; 76: 299-302.
39. Rose AG, Fraser RC, Beck W. Absence of evidence of myocarditis in endomyocardial biopsy specimens from patients with dilated (congestive) cardiomyopathy. S Afr Med J 1984; 66: 871-874.
40. Brink AJ, Torrington M, van der Walt JJ. Hereditary dysrhythmic congestive cardiomyopathy. S Afr Med J 1976; 50: 2119-2123.
41. Van der Merwe PL, Rose AG, van der Walt JJ, Weymar H W, Hunter JC, Weich H F. Progressive familial heart block type I. Clinical and pathological observations. S Afr Med J 1991; 80: 34-38.
42. Fernandez P, Moolman-Smook J, Brink P, Corfield V. A gene locus for progressive familial heart block type II (PFHBII) maps to chromosome 1q32.2-q32.3. Hum Genet 2005; 118: 133-137.
43. Przybojewski JZ, van der Walt JJ, van Eeden PJ, Tiedt FA. Familial dilated (congestive) cardiomyopathy. Occurrence in two brothers and an overview of the literature. S Afr Med J 1984; 66: 26-30.
44. Winship IM, Viljoen DL, Leary PM, De Moor MM. Microcephalycardiomyopathy: a new autosomal recessive phenotype? J Med Genet 1991; 28: 619-621.
45. Mayosi BM, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 1999; 36: 796-797.
46. Khogali SS, Mayosi BM, Beattie JM, McKenna WJ, Watkins H, Poulton J. A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 2001; 357: 1265-1267.
47. Candy G P, Skudicky D, Mueller UK, Woodiwiss AJ, Sliwa K, Luker F, et al. Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 740-744.
48. Badenhorst D, Norton GR, Sliwa K, Brooksbank R, Essop R, Sareli P, et al. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. Pharmacogenomics J 2007; 7: 339-345.
49. Du Preez J, Matolweni LO, Greenberg J, Mntla P, Adeyemo AA, Mayosi BM. The alpha 2C Del. 322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans. Cardiovasc J Afr 2008; 19: 15-16.
50. Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA. Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J S Afr 2003; 14: 145-155.
51. Mayosi BM, Somers K. Cardiomyopathy in Africa: heredity versus environment. Cardiovasc J Afr 2007; 18: 175-179.
52. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-693.
53. Brink AJ, Lewis CM. Coronary blood flow, energetics, and myocardial metabolism in idiopathic mural endomyocardiopathy (14 patients). Am Heart J 1967; 73: 339-348.
54. Brink AJ, Lewis CM, Bosman AR, Lochner A. Myocardial function and metabolism in idiopathic endomyocardial disease and subacute pericarditis, with a comparison of findings in cor pulmonale. An aid in differential diagnosis. Am J Cardiol 1969; 23: 667-672.
55. Brink AJ, Lewis CM. Idiopathic mural endomyocardiopathy: a study of coronary circulatory dynamics, myocardial energy metabolism, and cineaniographic appearances. Recent Adv Stud Cardiac Struct Metab 1973; 2: 717-737.
56. Chambers RJ, Beck W, Schrire V. Ventricular dynamics in Bantu cardiomyopathy. Am Heart J 1969; 78: 493-501.
57. Gotsman MS, Lewis BS, Mitha AS, Bakst A. Left ventricular performance in congestive cardiomyopathy. Recent Adv Stud Cardiac Struct Metab 1973; 2: 677-698.
58. Tiago AD, Badenhorst D, Skudicky D, Woodiwiss AJ, Candy G P, Brooksbank R, et al. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Cardiovasc Res 2002; 54: 584-589.
59. Maharaj B, Hammond MG. HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 65: 1402-1403.
60. Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998; 351: 1091-1093.
61. Sliwa K, Woodiwiss A, Libhaber E, Zhanje F, Libhaber C, Motara R, et al. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2004; 6: 731-734.
62. Brooksbank R, Woodiwiss A, Sliwa K, Deftereos D, Essop MR, Sareli P, et al. Sustained white cell cytokine activation in idiopathic dilated cardiomyopathy despite haemodynamic improvement with medical therapy. Cardiovasc J S Afr 2005; 16: 200-204.
63. Brooksbank R, Woodiwiss AJ, Sliwa K, Badenhorst D, Deftereos D, Wadee AA, et al. Endotoxin-independent white cell cytokine production in haemodynamically stable patients with idiopathic dilated cardiomyopathy. Cardiovasc J S Afr 2005; 16: 260-265.
64. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000; 35: 701-705.
65. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-446.
66. Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B, Arif G, et al. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005; 150: 263-269.
67. Batchelder K, Mayosi BM. Pentoxifylline for heart failure: a systematic review. S Afr Med J 2005; 95: 171-175.
68. Cosnett JE, Pudifin DJ. Embolic complications of cardiomyopathy. Br Heart J 1964; 26: 544-548.
69. Reid J V. The second heart sound in biventricular failure due to African cardiomyopathy. Am Heart J 1964; 68: 38-40.
70. Chesler E, Beck W. Incidence of conduction defects in African and coloured patients with congestive cardiomyopathy. Br Heart J 1973; 35: 799-804.
71. Chetty S, Mitha AS. Arrhythmias in idiopathic dilated cardiomyopathy. A preliminary study. S Afr Med J 1990; 77: 190-193.
72. Lowenthal MN. Hypertensive heart disease and cardiomyopathy in blacks. Diagnostic confusion. S Afr Med J 1979; 55: 547-549.
73. Mokhobo K P. Can hypertension masquerade as congestive cardiomyopathy? S Afr Med J 1980; 58: 1047-1048.
74. Inglis SC, Stewart S, Papachan A, Vaghela V, Libhaber C, Veriava Y, et al. Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy. Eur J Heart Fail 2007; 9: 384-390.
75. Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004; 93: 1441-1443, A10.
76. Beck W. Cardiomyopathies in South Africa - a brief survey of the problem and current therapeutic approaches. Postgrad Med J 1978; 54: 469-476.
77. Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, et al. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993; 21: 1094-1100.
78. Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, et al. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol 2004; 44: 1825-1830.
79. Marcus RH, Raw K, Patel J, Mitha A, Sareli P. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 1107-1112.
80. Lewis CM, Barnard PM, Van Der Walt JJ, Brink AJ. Haemodynamic basis for pericardiotomy as palliative treatment of idiopathic endomyocardiopathy. Recent Adv Stud Cardiac Struct Metab 1973; 2: 797-814.
81. Reid J V. Dietary therapy of cardiomyopathy. Recent Adv Stud Cardiac Struct Metab 1973; 2: 777-781.
82. Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation 2001; 103: 1083-1088.
83. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002; 4: 305-309.
84. Sliwa K, Woodiwiss A, Candy G, Badenhorst D, Libhaber C, Norton G, et al. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2002; 90: 1118-1122.
85. Beards SC, Freebairn RC, Lipman J. Successful use of continuous veno-venous haemofiltration to treat profound fluid retention in severe peripartum cardiomyopathy. Anaesthesia 1993; 48: 1065-1067.